ADAR1 Capital Management »

Springworks Therapeutics shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Springworks Therapeutics (SWTX) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Springworks Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Springworks Therapeutics held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Springworks Therapeutics by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $1.1M 24k 46.99
2025-03-31 $9.8M 223k 44.13
2024-09-30 $3.2k 100 32.04

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Keros Therapeutics (KROS)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Immunovant (IMVT)
89bio (ETNB)
Zai Lab Adr (ZLAB)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Uniqure Nv SHS (QURE)
Prothena Corp SHS (PRTA)
Bridgebio Pharma (BBIO)
Arbutus Biopharma (ABUS)

View all positions for ADAR1 Capital Management

Top funds holding Springworks Therapeutics

DekaBank Deutsche Girozentrale
Advisor Group Holdings
Huntington National Bank

View all funds holding Springworks Therapeutics